The association between hyperglycaemia and elevated troponin levels on mortality in acute coronary syndromes
Christopher P Gale1, Chetan Kashinath, Paul Brooksby
1Academic Unit of Cardiovascular Medicine, Leeds General Infirmary, Great George Street, Leeds, LS1 3EX, UK. medcpg@medphysics.leeds.ac.uk
Insights
Hyperglycaemia (high blood glucose) significantly increases one-year mortality risk in acute coronary syndrome patients. Even with guideline adherence, high glucose levels confer a long-term survival disadvantage.
Area of Science:
- Cardiology
- Endocrinology
- Clinical Medicine
Background:
- Diabetes mellitus is a known risk factor for cardiovascular disease.
- Hyperglycaemia is frequently observed in patients with acute coronary syndromes (ACS).
- The prognostic impact of hyperglycaemia on mortality in ACS patients requires further elucidation.
Purpose of the Study:
- To investigate the association between hyperglycaemia, troponin I levels, and one-year mortality in patients hospitalized with ACS.
- To determine if hyperglycaemia independently predicts mortality in this patient cohort.
Main Methods:
- Prospective study of 498 patients admitted with acute coronary syndrome.
- Measurement of random glucose and troponin I on admission.
- Follow-up for one-year mortality.
Main Results:
- Patients with hyperglycaemia (random glucose > 11.1 mmol/L) had a significantly higher proportion of deaths (27%) compared to those without (12%, p=0.002).
- Elevated troponin I concentrations on admission were associated with increased mortality (p<0.001).
- Myocardial infarction presence increased the risk of death (relative risk = 1.85).
Conclusions:
- Hyperglycaemia is a significant independent predictor of long-term mortality in patients with acute coronary syndrome.
- Even with optimal management, hyperglycaemia poses a substantial mortality risk.
- Close monitoring and management of glucose levels in ACS patients are crucial for improving outcomes.
Abstract:
Diabetes is associated with increased cardiovascular morbidity and mortality. We studied the relationship between hyperglycaemia, troponin I concentrations and one-year mortality in 498 subjects admitted to hospital with an acute coronary syndrome. The proportion of deaths was higher in those with hyperglycaemia (random glucose > 11.1 mmol/L) compared to those without (27% and 12%, respectively, Chi-squared test = 9.84, p=0.002). There was a difference in troponin I concentration on admission between those patients who were alive and dead (median and interquartile range 0.14 [0 to 3.90] and 2.98 [0.23 to 18.53] respectively, p<0.001) and the risk of death was elevated in those with a myocardial infarction compared to those without (relative risk = 1.85, 95% confidence intervals 1.55 to 2.21). Despite adherence to guidelines for the management of acute coronary syndromes, the presence of hyperglycaemia confers a significant long-term mortality disadvantage.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Hyperglycemia
Acute Coronary Syndrome V: Nursing Management
